Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Center Laboratories, Inc. (4123:TWSE), powered by AI.
Center Laboratories, Inc. is currently trading at $37.65. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Center Laboratories, Inc. on Alpha Lenz.
View Center Laboratories, Inc.'s valuation metrics on Alpha Lenz.
“Center Laboratories, Inc.'s ROE is 41.9%. Explore profitability and growth together.”
Ask for details →Center Laboratories, Inc. is a pharmaceutical company specializing in the development, manufacturing, and distribution of medications primarily within Taiwan and expanding internationally. The firm is recognized for a broad product portfolio that includes general pharmaceuticals such as antipyretics, analgesics, bronchodilators, anti-inflammatory and anti-allergy preparations, as well as a specialized focus on central nervous system treatments for conditions like cerebrovascular disease, dementia, and epilepsy. Additionally, the company is involved in drug research, cell therapy, biotechnology, and has interests in emerging sectors like hydrogen energy and dairy. Founded in 1959 and headquartered in Taipei City, Center Laboratories plays an important role in the healthcare industry, addressing diverse medical needs through both specialty and generic drug lines. The company's activities support advancements in pharmaceutical research and patient care, impacting healthcare outcomes across Taiwan and regional markets. Its consistent revenue growth, diversified operations, and commitment to research underline its significance within the Asian pharmaceutical landscape.
“Center Laboratories, Inc.'s ROE is 41.9%. Explore profitability and growth together.”
Ask for details →Center Laboratories, Inc. (ticker: 4123) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 37.65 with a P/E ratio of -x and P/B of -x.
ROE is 41.86% and operating margin is -23.88%. Annual revenue is $1.5B.